Page 1 of Clinical Trials for Drug extended-release guanfacine hydrochloride SPD503, 10 Total Matches
- 1CompletedLast Updated: October 28, 2011Condition(s): Attention-Deficit/Hyperactivity Disorder
- 2RecruitingLast Updated: May 9, 2012Condition(s): Attention Deficit Hyperactivity Disorder
- 3RecruitingLast Updated: December 5, 2011Condition(s): Attention-deficit/Hyperactivity Disorder
- 4RecruitingLast Updated: April 18, 2012Condition(s): Generalized Anxiety Disorder (GAD); Anxiety, Separation; Phobia, Social
- 5Enrolling by invitationLast Updated: March 16, 2012Condition(s): ADHD
- 6RecruitingLast Updated: May 15, 2012Condition(s): Attention-Deficit/Hyperactivity Disorder
- 7TerminatedLast Updated: March 29, 2012Condition(s): Attention-Deficit/Hyperactivity Disorder; Attention Deficit Disorder; Insomnia; Sleep Disorders
- 8CompletedLast Updated: February 10, 2012Condition(s): ADHD
- 9CompletedLast Updated: June 30, 2010Condition(s): Healthy
- 10CompletedLast Updated: July 1, 2010Condition(s): Healthy
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+extended-release+guanfacine+hydrochloride+SPD503
